The short version of Limit of detection fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-08. Anything still debated is marked as such rather than presented as settled.
Method validation establishes that an HPLC procedure is suitable for its intended use. Key parameters include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantitation, and robustness. Accuracy measures agreement with a true or accepted value, while precision describes repeatability and intermediate precision. Specificity confirms that the method measures the analyte without interference from impurities, degradants, or excipients. Validation is documented in a protocol and report, and acceptance criteria are set before experiments begin. Regulatory guidance varies by region, but the general principles are widely harmonized.
System suitability testing is performed before and during analytical runs to confirm that the instrument and method are working as expected. Common checks include retention time, peak area, resolution between critical pairs, tailing factor, and theoretical plate count. Results are compared with predefined limits, and a failed check requires investigation before sample results are reported. Quality control samples at low, middle, and high concentrations are injected at intervals to monitor accuracy and precision. Blank injections detect carryover and contamination, while control charts track performance over time.
Data handling and documentation are central to HPLC quality control. Electronic systems should have audit trails that record changes to methods, sequences, and results. Integration parameters, such as peak baseline and threshold, can affect reported areas and must be defined in advance. Out-of-specification results trigger a structured investigation that may include reanalysis, instrument checks, and review of sample preparation. Regulatory inspections often examine raw data, audit trails, and training records to verify that reported results are traceable and reliable.
Developing an HPLC method begins with defining the purpose, such as quantifying a main component, measuring impurities, or confirming identity. Analysts select separation mode, column, mobile phase, detection, and sample preparation based on analyte properties and matrix. Experiments vary solvent strength, pH, buffer type, and temperature to achieve resolution between critical peaks. The goal is a robust method that produces reliable results across instruments and operators. Method development often involves trial runs and statistical optimization.
Validation demonstrates that a method is suitable for its intended use. Typical performance characteristics include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantitation, and robustness. Regulators and standards organizations provide frameworks, but specific requirements depend on the application and jurisdiction. System suitability tests are run before sample analysis to confirm resolution, peak symmetry, retention time repeatability, and sensitivity. A validated method is not permanently fixed; changes may require partial or full revalidation.
| Property | Value | Notes |
|---|---|---|
| Validation parameter | Accuracy | Measured value compared with true or accepted value |
| Precision type | Repeatability | Same analyst, instrument, and short time interval |
| Linearity range | 50–150% of target concentration | Common for assay methods; method-dependent |
| Limit of quantitation | Signal-to-noise ratio of 10:1 | Lowest concentration with acceptable precision |
| Common synonyms | Method validation, analytical validation | Documented confirmation that a method is suitable |
System suitability testing is performed before and during analytical runs to confirm that the instrument and method are working as expected. Typical checks include retention time, peak area precision, resolution between critical pairs, tailing factor, and theoretical plate count. Acceptance criteria are set in the method or pharmacopeial monograph. If a suitability check fails, the run may be rejected and the instrument or sample preparation may need investigation. This practice helps prevent release of data from a system that has drifted out of control.
Quality control samples are inserted at intervals to monitor accuracy and precision throughout a batch. Blank samples detect contamination, while spiked samples assess recovery from the sample matrix. Calibration standards establish the relationship between detector response and concentration, and control samples are prepared independently from them whenever possible. Laboratories also participate in proficiency testing and maintain audit trails, instrument logs, and reagent records. Ongoing review of control charts can reveal trends before they cause out-of-specification results.
Documentation and traceability are central to regulated HPLC testing. Records typically include instrument logs, column history, mobile-phase preparation, sample preparation, injection sequences, raw chromatograms, and audit trails. Electronic systems may require user access controls, time-stamped changes, and backup procedures. Training records show that analysts are qualified for assigned methods. Audits and inspections check whether written procedures match actual practice and whether deviations are documented. These controls support reproducibility and allow results to be reconstructed if questions arise later.
Method validation establishes that an HPLC procedure is suitable for its intended purpose. Typical parameters include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantitation, robustness, and solution stability. Accuracy reflects closeness to a reference value, while precision reflects agreement among repeated measurements. Specificity shows whether the method can measure the analyte without interference from matrix components. Validation is documented through protocols and reports, and the required extent depends on the method's use and regulatory context.
Routine quality control uses system suitability, blank injections, check standards, and control samples to detect drift or contamination. System suitability criteria may specify minimum resolution, maximum tailing factor, and a permitted range for repeated injections. Blank injections reveal carryover or solvent contamination, while check standards confirm calibration accuracy over a batch. Control samples with known analyte levels can show whether results remain within statistical limits. When a control result falls outside limits, the analyst investigates the cause and may invalidate affected results before repeating the batch.
Separation in HPLC depends on the chemistry of the stationary phase, the composition of the mobile phase, and the physical properties of the column. Reverse-phase separations use a nonpolar stationary phase and a polar mobile phase, and they are common for many organic compounds. Ion-exchange, size-exclusion, and normal-phase modes serve other classes of analytes. Gradient elution changes solvent strength over time, while isocratic elution holds it constant. Flow rate, temperature, particle size, and column length all influence peak shape and resolution. Detection may use ultraviolet absorbance, fluorescence, refractive index, or mass spectrometry, depending on the analyte and the required sensitivity.
Routine HPLC testing compares a sample result with a calibration curve prepared from known reference standards. Peak area or peak height is plotted against concentration, and the curve is used to estimate unknown amounts. Retention time supports tentative identification when compared with a standard, though mass spectrometry or another confirmatory method may be needed for definitive identification. Pre-run checks verify repeatability, resolution, and peak symmetry before sample analysis. Limits of detection and quantification describe the smallest amounts that can be reliably observed or measured. Sample preparation, filtration, and degassing help prevent column damage and inconsistent results.
The third main set of standards is that the EU requires that electricity or gas enterprises acquire a licence from member state authorities. There must be legal separation into different entities of owners of networks from retailers, although they can be owned by the same enterprise, to ensure transparency of accounting. Then, different enterprises have rights to access infrastructure of network owners on fair and transparent terms, as a way to ensure different member state networks and supplies can become integrated across the EU. Most EU operators are publicly owned, and the Court of Justice in Netherlands v Essent NV emphatically rejected that there was any violation of EU law on free movement of capital by a Dutch Act requiring electricity and gas distributors to be publicly owned, that system operators could not be connected by ownership to generators, and limited the level of debt. The Court of Justice held a public ownership requirement was justified by 'overriding reasons in the public interest', 'to protect consumers' and for the 'security of energy supply'. It further pointed to the foundational case of Costa v ENEL, where the Court held in 1964 that the treaties do 'not prohibit the creation of any state monopolies' so long as they do not operate commercially and discriminate. The approach of EU law is that even where energy companies are privatised, they still are subject to the same rules as the state on direct effect, because it remains that they are 'providing a public service'.
Ultimately, the only physical mobilites that Eastlack had left were that of his face (his eyebrows, eyes, ears, nose, cheeks, and lips), his tongue, and partially his teeth and jaw, although this was extremely restricted. As the disease progressed and his bones ossified and he became more immobilized, Eastlack struggled more with routine movement and self-care. His family (especially his mother) would take care of him, but when she could no longer continue taking care of him as she grew older, Eastlack was then taken to a nursing home in Philadelphia, The Inglis House for the Incurables, which is now simply known as the Inglis House.
==== Natural fires ==== PAHs may result from the incomplete combustion of organic matter in natural wildfires. Substantially higher outdoor air, soil, and water concentrations of PAHs have been measured in Asia, Africa, and Latin America than in Europe, Australia, the U.S., and Canada.
Sources: en.wikipedia.org
=== Deconvolution of libraries cleaved from the solid support === If the synthesized molecules of a combinatorial library are cleaved from the solid support, a soluble mixture forms. In such solution, millions of different compounds may be found. When this synthetic method was developed, it first seemed impossible to identify the molecules, and to find molecules with useful properties. Strategies for identification of the useful components have been developed, however, to solve this problem. All these strategies are based on synthesis and testing of partial libraries. An early iterative strategy was devised by Furka in 1982. The method was later independently published by Erb et al. under the name "Recursive deconvolution"
=== NSAIDs === Nonsteroidal anti-inflammatory drugs (NSAIDs) and alcohol both increase gastrointestinal events such as gastrointestinal bleeding and peptic ulcers. Taking the two together further increases the risk additively. The risk of stomach bleeding is still increased when aspirin is taken with alcohol or warfarin.
In 1931, the Permanent Commission on Biological Standardisation of the League of Nations Health Organisation specified the provisional standards for vitamins A, B1, C, and D. These original standards were quite crude by modern measures: the standard for vitamin A was a mixture of many carotenoids, for vitamin B1 the result of adsorbing rice polishings onto fuller's earth, for vitamin C a sample of lemon juice, for vitamin D a sample of irradiated ergosterol in oil. In 1935, the standards for A, C, and D were changed to use pure substances: pure beta-carotene in oil, crystalline ascorbic acid, and crystalline ergocalciferol. This same commission also established early standards for biologics (antitoxins, insulins, pituitary extract and sex hormones) in the interwar period. In 1944, officials from the League of Nations, in cooperation with the Royal Society, established a first international standard for penicillin. The postwar World Health Organization established a second standard in 1953. Both were defined using a pure, crystalline substance.
== Research and development == Simcyp's R&D activities focus on the development of algorithms along with population and drug databases for modelling and simulation (M&S) of the absorption and disposition of drugs in patients and specific subgroups of patients across different age ranges. The Simcyp models use experimental data generated routinely during pre-clinical drug discovery and development from in vitro enzyme and cellular systems, as well as any relevant physico-chemical attributes of the drug and dosage forms. Some details of the scientific background of Simcyp approaches can be found in recent publications.
Sources: en.wikipedia.org
Nicotinic acid, or niacin, is an organic compound and a vitamer of vitamin B3, an essential human nutrient. It is produced by plants and animals from the amino acid tryptophan. Nicotinic acid is also a prescription medication. Amounts far in excess of the recommended dietary intake for vitamin functions will lower blood triglycerides and low density lipoprotein cholesterol (LDL-C), and raise blood high density lipoprotein cholesterol (HDL-C, often referred to as "good" cholesterol). There are two forms: immediate-release and sustained-release nicotinic acid. Initial prescription amounts are 500 mg/day, increased over time until a therapeutic effect is achieved. Immediate-release doses can be as high as 3,000 mg/day; sustained-release as high as 2,000 mg/day. Despite the proven lipid changes, nicotinic acid has not been found useful for decreasing the risk of cardiovascular disease in those already prescribed a statin drug. A 2010 review had concluded that nicotinic acid was effective as a mono-therapy, but a 2017 review incorporating twice as many trials concluded that prescription nicotinic acid, while affecting lipid levels, did not reduce all-cause mortality, cardiovascular mortality, myocardial infarctions, nor fatal or non-fatal strokes. Prescription nicotinic acid was shown to cause hepatotoxicity and increase risk of type 2 diabetes. Nicotinic acid prescriptions in the United States had peaked in 2009 at 9.4 million, declining to 800 thousand by 2020. In 2023, it was the 288th most commonly prescribed medication in the US, with more than 500,000 prescriptions.
Gattuso, J.-P.; Frankignoulle, M.; Wollast, R. (1998). "Carbon and carbonate metabolism in coastal aquatic ecosystems". Annual Review of Ecology and Systematics. 29 (1): 405–434. Bibcode:1998AnRES..29..405G. doi:10.1146/annurev.ecolsys.29.1.405. Gattuso, J.-P.; Frankignoulle, M.; Smith, S. V. (1999). "Measurement of community metabolism and significance of coral reefs in the CO2 source-sink debate". Proceedings of the National Academy of Sciences of the United States of America. 96 (23): 13017–13022. doi:10.1073/pnas.96.23.13017. PMC 23892. PMID 10557265. Kleypas, J. A.; Buddemeier, R. W.; Archer, D.; Gattuso, J.-P.; Langdon, C.; Opdyke, B. N. (1999). "Geochemical consequences of increased atmospheric CO2 on coral reefs". Science. 284 (5411): 118–120. doi:10.1126/science.284.5411.118. PMID 10102806. Gattuso, J.-P.; Allemand, D.; Frankignoulle, M. (1999). "Photosynthesis and calcification at cellular, organismal and community levels in coral reefs: a review on interactions and control by carbonate chemistry". American Zoologist. 39 (1): 160–183. doi:10.1093/icb/39.1.160. Gattuso, J.-P.; Gentili, B. W.; Duarte, C. M.; Kleypas, J.A.; Middelburg, J. J.; Antoine, D. (2006). "Light availability in the coastal ocean: impact on the distribution of benthic photosynthetic organisms and their contribution to primary production". Biogeosciences. 3 (4): 489–513. Bibcode:2006BGeo....3..489G. doi:10.5194/bg-3-489-2006. hdl:20.500.11937/23744. Gazeau, F.; Quiblier, C.; Jansen, J. M.; Gattuso, J.-P.; Middelburg, J. J.; Heip, C. H. R. (2007).
== Specialized hardware for MD simulations == Anton – A specialized, massively parallel supercomputer designed to execute MD simulations MDGRAPE – A special purpose system built for molecular dynamics simulations, especially protein structure prediction
The enzyme was incorrectly classified as acting on a CH-OH group EC 1.1.3.23: Thiamine oxidase EC 1.1.3.24: L-galactonolactone oxidase EC 1.1.3.25: Now included with EC 1.1.99.18, cellobiose dehydrogenase (acceptor) EC 1.1.3.26: Now EC 1.21.3.2, columbamine oxidase EC 1.1.3.27: hydroxyphytanate oxidase EC 1.1.3.28: nucleoside oxidase EC 1.1.3.29: N-acylhexosamine oxidase EC 1.1.3.30: polyvinyl-alcohol oxidase EC 1.1.3.31: deleted, cannot be distinguished from EC 1.1.3.13, alcohol oxidase EC 1.1.3.32: Now EC 1.14.21.1, (S)-stylopine synthase EC 1.1.3.33: Now EC 1.14.21.2, (S)-cheilanthifoline synthase EC 1.1.3.34: Now EC 1.14.21.3, berbamunine synthase EC 1.1.3.35: Now EC 1.14.21.4, salutaridine synthase EC 1.1.3.36: Now EC 1.14.21.5, (S)-canadine synthase EC 1.1.3.37: D-arabinono-1,4-lactone oxidase EC 1.1.3.38: vanillyl-alcohol oxidase EC 1.1.3.39: nucleoside oxidase (H2O2-forming) EC 1.1.3.40: D-mannitol oxidase EC 1.1.3.41: xylitol oxidase EC 1.1.3.42: prosolanapyrone-II oxidase EC 1.1.3.43: paromamine 6′-oxidase EC 1.1.3.44: 6′′′-hydroxyneomycin C oxidase EC 1.1.3.45: aclacinomycin-N oxidase EC 1.1.3.46: 4-hydroxymandelate oxidase EC 1.1.3.47: 5-(hydroxymethyl)furfural oxidase EC 1.1.3.48: 3-deoxy-α-D-manno-octulosonate 8-oxidase EC 1.1.3.49: (R)-mandelonitrile oxidase
The epithelial layer, known as mesothelium, consists of a single layer of avascular flat nucleated cells (simple squamous epithelium) which produce the lubricating serous fluid. This fluid has a consistency similar to thin mucus. These cells are bound tightly to the underlying connective tissue. The connective tissue layer provides the blood vessels and nerves for the overlying secretory cells, and also serves as the binding layer which allows the whole serous membrane to adhere to organs and other structures. For the heart, the layers of the serous membrane are called the parietal pericardium, and the visceral pericardium (sometimes called the epicardium). Other parts of the body may also have specific names for these structures. For example, the serosa of the uterus is called the perimetrium.
Sources: en.wikipedia.org
System suitability is a set of checks that confirm the instrument and method perform within limits before sample analysis. It typically includes resolution, tailing factor, retention time, and peak area reproducibility. If a check fails, the run is invalidated until the cause is resolved.
QC samples are usually injected at the beginning, at intervals during the run, and at the end. The exact frequency depends on the method, sample count, and regulatory requirements. Results outside acceptance limits can require rejection of the affected samples and investigation.
Method validation demonstrates that an HPLC procedure produces reliable results for its intended purpose. It provides documented evidence for accuracy, precision, specificity, and other performance characteristics. Regulators and quality systems require validation before a method is used for release or stability testing.
It is a set of checks performed before or during an HPLC run to confirm the system works as expected. Parameters may include resolution, tailing factor, theoretical plates, and retention time precision. Failure can trigger maintenance, method adjustment, or repeat analysis.